Zojuist op LinkedIn
We are excited to discuss our mission, our therapies, and our roadmap at Web Summit 2024 next week in Lisbon, Portugal.
Our CEO, Dave Marver, will join Adrien Cohen, of SCI Ventures, for the November 12th panel about how investing can help address the unmet needs of those with hashtag#spinalcordinjury (SCI).
Katherine Ward, of Global News Canada, will moderate the discussion about translating these hashtag#medtech breakthroughs from the lab to the clinic.
Thank you, Web Summit for shining a light on these innovative therapies for the SCI Community. We look forward to a thoughtful conversation! ??
?? Link to Web Summit in comments.
Note: All ONWARD® Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.